Ensysce Biosciences (ENSC US)

Analysis

Health Care • United States

Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.

Refresh

Company Presentation • 05 Aug 2026 21:00

Investor presentation

Company Presentation • 20 Apr 2026 19:00

Investor presentation

Company Presentation • 14 Aug 2025 19:00

Investor Presentation

Company Presentation • 28 Jan 2020 08:55

Investor Presentation

No more presentations

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00